Vitamin B niacin offers no extra benefit to statin therapy in seniors already diagnosed with coronary artery disease, study suggests

The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study shows.

Visit link:
Vitamin B niacin offers no extra benefit to statin therapy in seniors already diagnosed with coronary artery disease, study suggests